• Phosphatase Inhibitor Cocktail 3: Enhancing Phosphoprotein A

  2026-05-28

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) streamlines the preservation of protein phosphorylation, enabling reliable phosphoprotein analysis across Western blotting, kinase assays, and co-IP workflows. This APExBIO solution uniquely targets key serine/threonine phosphatases, ensuring signal fidelity even in challenging cellular signaling studies.

• Actinomycin D in Cancer Research: Applied Workflows & Optimi

  2026-05-28

  Actinomycin D (ActD) is a gold-standard transcriptional inhibitor powering advanced cancer research and RNA stability assays. This article breaks down best-practice workflows, experimental troubleshooting, and actionable insights from breakthrough glioma studies, leveraging APExBIO’s high-purity formulation for reproducible, high-impact results.

• HyperFluor 488 Goat Anti-Human IgG Antibody: Workflow Master

  2026-05-27

  The HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody elevates immunofluorescence and immunoassay workflows with high sensitivity, specificity, and robust signal amplification. Its versatility streamlines advanced detection in Western blotting, flow cytometry, and multiplexed applications, supporting high-impact translational research.

• Ether Lipid Biosynthesis in B Cells Regulates Antibody Respo

  2026-05-27

  This study uncovers how B cell-intrinsic expression of PexRAP, a key enzyme in ether lipid biosynthesis, directly influences antibody affinity maturation and germinal center development. The findings highlight a metabolic mechanism that shapes humoral immunity, with implications for immunology research and advanced mouse model design.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-05-26

  Anlotinib hydrochloride is a potent multi-target tyrosine kinase inhibitor with nanomolar efficacy against VEGFR2, PDGFRβ, and FGFR1. It demonstrates strong anti-angiogenic activity and favorable pharmacokinetics for cancer research. APExBIO's C8688 formulation offers validated selectivity and workflow reproducibility.

• Vardenafil HCl Trihydrate: Precision Tools for PDE5 Isoform

  2026-05-26

  Explore how Vardenafil HCl Trihydrate empowers researchers to dissect PDE5 isoform selectivity and proteoform-specific interactions, advancing cGMP signaling pathway studies. This article offers a unique, in-depth perspective on using Vardenafil in native proteomics and assay design.

• SAR405: Decoding Vps34 Inhibition for Selective Autophagy Co

  2026-05-25

  Explore how SAR405, a potent Vps34 inhibitor, enables precise autophagy inhibition and vesicle trafficking studies. This article uniquely bridges mechanistic insights with practical assay design, integrating new paradigms from recent AMPK research.

• Cy3 NHS ester (non-sulfonated): Technical Guide for Biomolec

  2026-05-25

  Cy3 NHS ester (non-sulfonated) enables precise fluorescent labeling of proteins, peptides, and oligonucleotides by targeting primary amines. It is best applied where robust, organic-solvent-compatible labeling is required and is not suitable for workflows that demand strict aqueous-only conditions or for labeling delicate proteins without a co-solvent.

• Anti-Fibrotic Action of 1-Phenyl-2-Pentanol in Hepatic Stell

  2026-05-24

  This study identifies 1-phenyl-2-pentanol, isolated from Moringa oleifera, as a potent inhibitor of hepatic stellate cell activation through dual modulation of TGF-β1 and Wnt/β-catenin pathways. The findings provide mechanistic insight into anti-fibrotic therapy development and inform experimental modeling of liver fibrosis.

• Structural Insights into Nipah Virus Polymerase Complex Asse

  2026-05-23

  The reference study delivers high-resolution structures of the Nipah virus L-P polymerase complex, uncovering the molecular organization and interactions essential for viral RNA synthesis. These findings provide a crucial foundation for structure-based antiviral development targeting henipavirus replication machinery.

• SAR405: Redefining Vps34 Inhibition for Autophagy Research

  2026-05-22

  Explore how SAR405, a highly selective Vps34 inhibitor, enables unprecedented precision in dissecting autophagy and vesicle trafficking. This article delivers new scientific depth and protocol guidance, building on recent discoveries in AMPK-ULK1-Vps34 signaling.

• Beyond Disulfide Reduction: Advanced Roles of TCEP Hydrochlo

  2026-05-22

  Explore how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is redefining protein modification and assay sensitivity, with a deep dive into its mechanistic impact on modern biochemical workflows. Learn why APExBIO’s TCEP hydrochloride is pivotal for advanced protein analysis and innovative capture-and-release strategies.

• HOBt (1-Hydroxybenzotriazole) in Peptide Synthesis Workflows

  2026-05-21

  HOBt (1-Hydroxybenzotriazole) streamlines amide bond formation by minimizing epimerization and boosting coupling efficiency, critical for high-fidelity peptide and antibiotic derivative synthesis. This article details workflow enhancements, troubleshooting, and practical tips for maximizing HOBt’s impact, drawing from both literature and cutting-edge applied research.

• Molnupiravir Blocks Bourbon Virus Pathology in Mice Models

  2026-05-21

  This study demonstrates that molnupiravir, a broad-spectrum antiviral, effectively inhibits Bourbon virus replication and prevents lethal disease in a mouse model. The findings advance understanding of nucleoside analogue efficacy against emerging tick-borne RNA viruses and highlight avenues for translational antiviral research.

• CB-5083: Precision Disruption of Protein Homeostasis in Onco

  2026-05-20

  Explore how CB-5083, a potent p97 inhibitor, enables next-level oncology research by precisely disrupting protein homeostasis. This article uniquely integrates structural, mechanistic, and translational insights while guiding practical assay design.

16016 records 1/1068 page Next 12345 下5页 Last page